This website is intended for Healthcare Professionals outside of the UK and the US.

Symptoms Of Scpcd Cover Desktop

SCPCD action tool

SUGGESTED ACTIONS WHEN FACING PURPURA FULMINANS

This is an action tool that has been created by Shire and is based on varying clinical practices and publications

Decision Action Tool Desktop

For information only. Treatment decisions should always be based on the label of approved medications, and clinical training and expertise.

Learn more about how to treat SCPCD

 

*There are other coagulation disorders that contribute to similar symptoms; #Steps 1 and 2 should be performed in parallel;
**Please refer to “Options for management of SCPCD” page of this website for treatment options; # Rarely, patients with moderate protein C activity have also presented with neonatal PF; ##Generic analysis needs to be done to confirm SCPCD.
***Genetic analysis needs to be done to confirm SCPCD.

FFP=Fresh frozen plasma; HB=Haemoglobin; INR=International Normalized Ratio; OAC=Oral anticoagulation; PC=Protein C; PF=Purpura fulminans; PS=Protein S; SCPCD=Severe congenital protein C deficiency; WCC= White cell count.

REFERENCES:

Napolitano LM, et al. Sepsis 2018: Definitions and Guideline Changes. Surg Infect. 2018;19:117-125.

Knoebl PN. Blood coagulation and inflammation in critical illness: the importance of the protein C pathway. UNI-MED Verlag; 2008.

Chalmers E, et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child. 2011;96:1066-1071.

Goldenberg NA, et al. Protein C deficiency. Haemophilia. 2008;14:1214-1221.

Price VE, et al. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med. 2011;16(6):318-322.

Khor B, et al. Laboratory tests for protein C deficiency. Am J Hematol. 2010;85:440-442.

Libourel EJ, et al. Protein C/S ratio, an accurate and simple tool to identify carriers of a protein C gene mutation. Br J Haematol. 2002;118:615-618.

Tcheng WY, et al. Severe congenital protein c deficiency: description of a new mutation and prophylactic protein C therapy and in vivo pharmacokinetics. Pediatr Hematol Oneal. 2008; 30: 166-71.

SCPCD - ACTION TOOL Decision White (2)

Interested in Severe Congenital Protein C Deficiency (SCPCD) and its management?
Sign up below!

Sorry! There are some errors below that need to be fixed.
There seems to have been an error when sending the form.

You have the right to opt out of receiving such electronic communications at any time by using the opt out link in the communication you will receive or by contacting us at privacyconnect@shire.com. For more information on how Shire processes your personal data, please refer to our Privacy Notice.

Please include @ in your email adress
*Required
Register

Thanks

Thank you for submitting your details

You are about to leave this website. Shire has no influence or control over the content of this third party website.
Continue Cancel
WELCOME TO SCPCD.org
This site is intended for healthcare professionals outside of the US and UK. Please verify that you are a healthcare professional by checking one of the boxes below :
Please tick the boxes to enter the site

Yes, I am a healthcare professional outside of the US and UK

YES

No, I am not a healthcare professional outside of the US and UK

NO